Dr. Zanni is a psychologist and health-systems specialist based in Alexandria, Virginia.
According to a recent survey by Harris Interactive, 46% of adults are extremely or very concerned about adverse reactions when taking prescription drugs as directed. The same Harris poll found that patients' fears impact adherence. The following were reported among all adults who have ever taken prescription drugs1:
Although 46% of patients have fears concerning potential adverse effects, pharmacists spend <25% of their time consulting with patients.2 Reasons for this disconnect are well known by all pharmacists—understaffing and time management.
Patients are concerned with 4 essential aspects with regard to medication information: the agent's purpose, side effects, directions for taking it, and the dos and don'ts associated with the agent.3 Most patients prefer receiving information from practitioners, but 160 million Americans also turn to the Internet; 84% of all online adults search the Internet an average of 5.7 times per month for health information, and up to 55% of this group query physicians on Internet information.4 Patients also react to media health news; it is not unusual for patients to bombard practitioners with questions after media reports on FDA recalls and black-box warnings. It should be noted that 86% of Americans aged 50 and older hold favorable opinions of pharmacists—a statistic that exceeds favorable opinions of physicians (84%).5
Pollsters are regularly assessing Americans' health care beliefs and actions. The Table summarizes some of the more recent results. Please note that survey findings should be viewed cautiously; sampling error, sample size, wording, interviewer effects, and participant refusal affect accuracy. Although pollsters hope their survey samples represent a cross section of the population, sampling error always exists.
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs